Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
89.70
-8.80 (-8.93%)
At close: Apr 4, 2025, 4:00 PM
90.00
+0.30 (0.33%)
After-hours: Apr 4, 2025, 4:29 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 107.23, with a low estimate of 78 and a high estimate of 130. The average target predicts an increase of 19.54% from the current stock price of 89.70.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 10, 2025.
Analyst Ratings
The average analyst rating for Boston Scientific stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $115 → $120 | Strong Buy | Maintains | $115 → $120 | +33.78% | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $111 → $118 | Buy | Maintains | $111 → $118 | +31.55% | Feb 10, 2025 |
| UBS | UBS | Strong Buy Maintains $105 → $130 | Strong Buy | Maintains | $105 → $130 | +44.93% | Feb 7, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $119 → $122 | Strong Buy | Maintains | $119 → $122 | +36.01% | Feb 6, 2025 |
Financial Forecast
Revenue This Year
19.36B
from 16.75B
Increased by 15.60%
Revenue Next Year
21.35B
from 19.36B
Increased by 10.28%
EPS This Year
2.89
from 1.25
Increased by 131.15%
EPS Next Year
3.30
from 2.89
Increased by 14.07%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.6B | 22.8B | 25.0B | ||
| Avg | 19.4B | 21.4B | 23.5B | ||
| Low | 18.6B | 20.4B | 22.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.2% | 17.8% | 16.9% | ||
| Avg | 15.6% | 10.3% | 9.9% | ||
| Low | 11.2% | 5.2% | 4.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.11 | 3.70 | 4.07 | ||
| Avg | 2.89 | 3.30 | 3.72 | ||
| Low | 2.77 | 3.10 | 3.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 148.6% | 27.9% | 23.6% | ||
| Avg | 131.2% | 14.1% | 12.8% | ||
| Low | 121.9% | 7.2% | 4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.